Antitumor agent or postoperative adjuvant chemotherapeutic agent for treatment of hepatocellular carcinoma

Details for Australian Patent Application No. 2010336256 (hide)

Owner Taiho Pharmaceutical Co., Ltd.

Inventors Oka, Toshinori

Agent Shelston IP

Pub. Number AU-A-2010336256

PCT Pub. Number WO2011/078311

Priority 2009-295909 25.12.09 JP

Filing date 24 December 2010

Wipo publication date 30 June 2011

International Classifications

C07D 403/06 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/404

A61P 35/00 Antineoplastic agents

Event Publications

19 July 2012 PCT application entered the National Phase

  PCT publication WO2011/078311 Priority application(s): WO2011/078311

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010336257-Method for predicting therapeutic effect of chemotherapy on hepatocellular carcinoma patient

2010336253-Gene Dro1 controlling deep-rooted characteristics of plant and utilization of same